These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24766462)

  • 1. Early and late HIV-1 membrane fusion events are impaired by sphinganine lipidated peptides that target the fusion site.
    Klug YA; Ashkenazi A; Viard M; Porat Z; Blumenthal R; Shai Y
    Biochem J; 2014 Jul; 461(2):213-22. PubMed ID: 24766462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M; Furman C; Helseth E; Repke H; Sodroski J
    J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.
    Tang X; Jin H; Chen Y; Li L; Zhu Y; Chong H; He Y
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors.
    Herschhorn A; Finzi A; Jones DM; Courter JR; Sugawara A; Smith AB; Sodroski JG
    PLoS One; 2011; 6(11):e26731. PubMed ID: 22069466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
    Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
    PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.
    Geng X; Liu Z; Yu D; Qin B; Zhu Y; Cui S; Chong H; He Y
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31277353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.
    Grupping K; Selhorst P; Michiels J; Vereecken K; Heyndrickx L; Kessler P; Vanham G; Martin L; Ariën KK
    Retrovirology; 2012 May; 9():36. PubMed ID: 22551420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.
    Jacobs A; Garg H; Viard M; Raviv Y; Puri A; Blumenthal R
    Vaccine; 2008 Jun; 26(24):3026-35. PubMed ID: 18242797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.
    Platt EJ; Gomes MM; Kabat D
    J Virol; 2014 Apr; 88(8):4304-18. PubMed ID: 24478426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor.
    Yu D; Ding X; Liu Z; Wu X; Zhu Y; Wei H; Chong H; Cui S; He Y
    J Biol Chem; 2018 Aug; 293(33):12703-12718. PubMed ID: 29929981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion.
    Pleskoff O; Seman M; Alizon M
    J Virol; 1995 Jan; 69(1):570-4. PubMed ID: 7983757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.
    Rosemary Bastian A; Nangarlia A; Bailey LD; Holmes A; Kalyana Sundaram RV; Ang C; Moreira DR; Freedman K; Duffy C; Contarino M; Abrams C; Root M; Chaiken I
    J Biol Chem; 2015 Jan; 290(1):529-43. PubMed ID: 25371202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingopeptides: dihydrosphingosine-based fusion inhibitors against wild-type and enfuvirtide-resistant HIV-1.
    Ashkenazi A; Viard M; Unger L; Blumenthal R; Shai Y
    FASEB J; 2012 Nov; 26(11):4628-36. PubMed ID: 22872679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
    Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
    J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Berger EA; Lifson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike.
    Eggink D; de Taeye SW; Bontjer I; Klasse PJ; Langedijk JPM; Berkhout B; Sanders RW
    J Virol; 2016 Dec; 90(23):10587-10599. PubMed ID: 27654295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    Doranz BJ; Baik SS; Doms RW
    J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.